申请人:——
公开号:US20040138272A1
公开(公告)日:2004-07-15
Allylic compounds represented by the formula (I) are provided,
1
wherein each of R
1
to R
8
, m, n, A and X are as defined in the Specification. These compounds can inhibit Rho kinase, and can find utility in repair of damaged nerves in the central and peripheral nervous system by inducing axon growth and regeneration, and in the treatment by inhibition of Rho kinase in disease states in which Rho kinase is implicated. The compounds are relatively cell permeable and pharmaceutical compositions thereof can promote neurite growth and are also useful for the prevention of cell proliferation in malignant deseases.
提供了由公式(I)表示的烯丙基化合物,其中R1至R8、m、n、A和X的定义如规范中所述。这些化合物可以抑制Rho激酶,并且可以通过诱导轴突生长和再生,在中枢和外周神经系统中修复受损神经,并在Rho激酶参与的疾病状态中通过抑制Rho激酶进行治疗。这些化合物相对细胞渗透性较强,其制剂可以促进神经节突生长,并且还可用于预防恶性疾病中的细胞增殖。